Dick Pluim

5.2k total citations · 1 hit paper
70 papers, 4.2k citations indexed

About

Dick Pluim is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dick Pluim has authored 70 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 29 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dick Pluim's work include Cancer therapeutics and mechanisms (16 papers), Drug Transport and Resistance Mechanisms (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). Dick Pluim is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Drug Transport and Resistance Mechanisms (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). Dick Pluim collaborates with scholars based in Netherlands, United States and Italy. Dick Pluim's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Marc Maliepaard, Olaf van Tellingen, Pauline Breedveld, Robert C.A.M. van Waardenburg, Matthijs M. Tibben and Alfred H. Schinkel and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Dick Pluim

70 papers receiving 4.1k citations

Hit Papers

A Phase I and Pharmacolog... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
    2004 760 citations Dick Pluim, Jos H. Beijnen et al. Clinical Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dick Pluim 2.8k 1.6k 899 425 419 70 4.2k
Pranav Gupta 2.1k 0.8× 1.8k 1.2× 702 0.8× 289 0.7× 205 0.5× 77 3.9k
Walter J. Loos 3.3k 1.2× 2.3k 1.5× 273 0.3× 569 1.3× 529 1.3× 135 5.6k
Patric J. Jansson 2.4k 0.8× 2.6k 1.7× 981 1.1× 227 0.5× 116 0.3× 85 5.5k
Pierantonio Menna 1.8k 0.6× 1.6k 1.0× 423 0.5× 548 1.3× 155 0.4× 65 4.8k
Emanuela Salvatorelli 1.7k 0.6× 1.5k 1.0× 417 0.5× 543 1.3× 139 0.3× 56 4.7k
K. Mross 3.1k 1.1× 2.1k 1.4× 311 0.3× 302 0.7× 174 0.4× 148 5.2k
Kenneth R. Harrap 2.3k 0.8× 1.9k 1.2× 963 1.1× 181 0.4× 145 0.3× 108 4.3k
Renzo Canetta 2.2k 0.8× 894 0.6× 344 0.4× 208 0.5× 150 0.4× 61 3.9k
Catherine Booth-Genthe 1.8k 0.6× 1.7k 1.1× 227 0.3× 568 1.3× 315 0.8× 13 3.3k
Mary K. Danks 2.0k 0.7× 3.4k 2.2× 503 0.6× 117 0.3× 149 0.4× 99 5.0k

Countries citing papers authored by Dick Pluim

Since Specialization
Citations

This map shows the geographic impact of Dick Pluim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick Pluim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick Pluim more than expected).

Fields of papers citing papers by Dick Pluim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick Pluim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick Pluim. The network helps show where Dick Pluim may publish in the future.

Co-authorship network of co-authors of Dick Pluim

This figure shows the co-authorship network connecting the top 25 collaborators of Dick Pluim. A scholar is included among the top collaborators of Dick Pluim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dick Pluim. Dick Pluim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandsma, Dieta, Els Verhoeven, Kim Monkhorst, et al.. (2025). Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid. European Journal of Cancer. 229. 115783–115783. 1 indexed citations
2.
Pluim, Dick, et al.. (2024). ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluid. Journal of Pharmaceutical and Biomedical Analysis. 245. 116140–116140. 1 indexed citations
3.
Baarslag, Manuel A., Joosje H. Heimovaara, Jessica S.W. Borgers, et al.. (2023). Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab. New England Journal of Medicine. 389(19). 1790–1796. 14 indexed citations
4.
5.
Heuvel, Michel M. van den, Judi van Diessen, Heike Peulen, et al.. (2020). Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(5). 1256–1266. 39 indexed citations
6.
Bussel, Mark T. J. van, Dick Pluim, Bojana Milojkovic Kerklaan, et al.. (2020). Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. Neurology. 94(5). e521–e528. 51 indexed citations
7.
Jacobs, Bart, Dick Pluim, Hilde Rosing, et al.. (2020). Phase I pharmacological study of continuous chronomodulated capecitabine treatment. Pharmaceutical Research. 37(5). 89–89. 13 indexed citations
8.
Jacobs, Bart, Dick Pluim, Hilde Rosing, et al.. (2018). Phase I pharmacological study of continuous chronomodulated capecitabine treatment. Annals of Oncology. 29. viii662–viii663. 1 indexed citations
9.
Gorelova, Vera, Jeroen Van Daele, Dick Pluim, et al.. (2017). Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants. The Plant Cell. 29(11). 2831–2853. 68 indexed citations
10.
11.
Jacobs, Bart, Hilde Rosing, Dick Pluim, et al.. (2016). A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine. Cancer Chemotherapy and Pharmacology. 77(6). 1201–1207. 4 indexed citations
12.
Marchetti, Serena, Dick Pluim, Jos H. Beijnen, et al.. (2014). “Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”. Investigational New Drugs. 32(6). 1083–1095. 9 indexed citations
13.
Leijen, Suzanne, Sjaak A. Burgers, Paul Baas, et al.. (2014). Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy. Investigational New Drugs. 33(1). 201–214. 321 indexed citations
14.
Lin, Fan, Serena Marchetti, Dick Pluim, et al.. (2013). Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues. Clinical Cancer Research. 19(8). 2084–2095. 38 indexed citations
15.
Pluim, Dick, et al.. (2013). Pharmacodynamic assay of thymidylate synthase activity in peripheral blood mononuclear cells. Analytical and Bioanalytical Chemistry. 405(8). 2495–2503. 6 indexed citations
16.
Pluim, Dick, Lot A. Devriese, Jos H. Beijnen, & Jan H.M. Schellens. (2012). Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular‐signal‐regulated kinase and DNA in circulating tumor cells. Cytometry Part A. 81A(8). 664–671. 24 indexed citations
17.
Boss, David S., Dick Pluim, Hilde Rosing, et al.. (2009). Phase I Pharmacokinetic and Pharmacodynamic Study of Carboplatin and Topotecan Administered Intravenously Every 28 Days to Patients with Malignant Solid Tumors. Clinical Cancer Research. 15(13). 4475–4483. 1 indexed citations
18.
Breedveld, Pauline, Noam Zelcer, Dick Pluim, et al.. (2004). Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles. Cancer Research. 64(16). 5804–5811. 190 indexed citations
19.
Waardenburg, Robert C.A.M. van, Maria A.J. van Eijndhoven, C. Verseyden, et al.. (2004). Platinated DNA Adducts Enhance Poisoning of DNA Topoisomerase I by Camptothecin. Journal of Biological Chemistry. 279(52). 54502–54509. 36 indexed citations
20.
Herben, Virginie M.M., et al.. (2002). Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel–cisplatin–topotecan in a phase I study. Anti-Cancer Drugs. 13(1). 87–91. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pranav Gupta Breakdown of academic impact, for papers by Walter J. Loos Breakdown of academic impact, for papers by Patric J. Jansson Breakdown of academic impact, for papers by Pierantonio Menna Breakdown of academic impact, for papers by Emanuela Salvatorelli Breakdown of academic impact, for papers by K. Mross Breakdown of academic impact, for papers by Kenneth R. Harrap Breakdown of academic impact, for papers by Renzo Canetta Breakdown of academic impact, for papers by Catherine Booth-Genthe Breakdown of academic impact, for papers by Mary K. Danks
Rankless by CCL
2026